MassMutual Private Wealth & Trust’s BridgeBio Pharma BBIO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.2K	Buy	43 +6	+16%	+$420	﹤0.01%	1848
2026 Q1	$2.75K	Buy	37 +2	+6%	+$145	﹤0.01%	1889
2025 Q4	$2.68K	Buy	35 +2	+6%	+$131	﹤0.01%	1912
2025 Q3	$1.71K	Hold	33	–	–	﹤0.01%	2028
2025 Q2	$1.43K	Sell	33 -10	-23%	-$364	﹤0.01%	2036
2025 Q1	$1.49K	Buy	+43	New	+$1.45K	﹤0.01%	2012
2022 Q1	–	Sell	-54	Closed	-$1K	–	1513
2021 Q4	$1K	Buy	+54	New	+$2.29K	﹤0.01%	1172

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

MassMutual Private Wealth & Trust's BBIO Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its BridgeBio Pharma (BBIO) stake by 16% in Q2 2026, buying an estimated $420 and bringing the position to 43 shares worth $3.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

MassMutual Private Wealth & Trust first reported a position in BBIO in Q4 2021 and has held it in 7 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

MassMutual Private Wealth & Trust held 43 shares of BridgeBio Pharma worth $3.2K as of Q2 2026.
MassMutual Private Wealth & Trust bought 6 BridgeBio Pharma shares in Q2 2026, an estimated $420.
BridgeBio Pharma made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1848 holding.
MassMutual Private Wealth & Trust first reported a position in BridgeBio Pharma in Q4 2021 and has held it in 7 quarters since.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.